Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia

by Claudia Tandler, Moritz Schmidt, Jonas S. Heitmann, Julia Hierold, Jonas Schmidt, Pascal Schneider, Daniela Dörfel, Juliane Walz, Helmut R. Salih
Published 2020-09-01